Molecular Mechanisms of Stress Signaling in the Female Heart
Molecular Mechanisms of Stress Signaling in the Female Heart
批准号:
10548742
负责人:
Diana Cruz Topete
金额:
$13.88万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-15 至 2024-12-31
关键词:
AffectAgeAge YearsAmericanApoptosisApoptoticBindingBiological AssayCardiacCardiac MyocytesCardiac healthCardiovascular systemCaspaseCause of DeathCell DeathCell membraneCellsCessation of lifeClinical TrialsComplexCytochromesCytoplasmDataDiseaseElementsEstrogen Nuclear ReceptorEstrogen Receptor alphaEstrogen ReceptorsEstrogensExposure toFemaleFlow CytometryFundingFunding MechanismsGRP geneGenderGene ExpressionGenesGenetic PolymorphismGenetic TranscriptionGenomicsGenus HippocampusGlucocorticoid ReceptorGlucocorticoidsGoalsGonadal Steroid HormonesGrantHealthHeartHeart DiseasesHeart failureHormone ReceptorHormonesHumanHypoxiaIn Situ Nick-End LabelingIncidenceIncubatedInfarctionInjuryInstitutionIschemiaKnock-outLeadLinkMAPK3 geneMeasuresMediatingMembrane PotentialsMentorsMitochondriaModelingMolecularMusMyocardialMyocardial InfarctionMyocardial IschemiaMyocardiumNuclear EnvelopeNuclear ReceptorsOutcomeOxygen ConsumptionPathway interactionsPermeabilityPharmacological TreatmentPhysiologicalPredispositionPrevalenceProteinsProtonsReceptor InhibitionReceptor SignalingRecoveryRecurrenceRegulationReperfusion InjuryReperfusion TherapyRepressionResearchRiskRisk FactorsSLC25A4 geneSamplingSerotoninSerotonin Receptor 5-HT2BSignal PathwaySignal TransductionSmall Interfering RNAStainsStimulusStressSystemTestingTherapeutic InterventionTrainingTranscriptional RegulationWestern BlottingWomanWritingantagonistbiological adaptation to stresscardioprotectioncareercareer developmentchromatin immunoprecipitationdepressed patientheart functionhigh riskhuman femaleimprovedin vivomenmitochondrial dysfunctionmitochondrial membranemortalitymortality riskmyocardial injurypromoterprotective effectresponseserotonin 5 receptorserotonin receptorsexsexual dimorphismskills
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The prevalence of heart attacks has increased among women between 35-50 years of age compared to men of
the same age. In contrast to men, women have a higher risk of mortality and complications after a heart attack
due to the under-representation of women in clinical trials, the lack of gender-tailored pharmacological
treatments, and potential higher vulnerability of women than for men to traditional and emerging risk factors.
Stress has emerged as an important risk factor for heart disease in women; stress levels have been shown to
correlate with delayed recovery, recurrence, and increased mortality after a heart attack in women. Sex
hormones are considered the critical regulators of the physiological differences between men and women in
health and disease. These hormones certainly contribute to sexual dimorphism in heart disease; however, the
effects of gender on the incidence and outcomes of a heart attack are more complex and are unlikely to be due
to sex hormones alone. The goal of the present proposal is to define one of the signaling pathways underlying
the deleterious effects of stress on female cardiac health in the setting of myocardial ischemia (heart attack). To
accomplish this goal, we propose to investigate the mechanisms whereby glucocorticoids (the primary stress
hormones) affects estrogen cardioprotection in myocardial ischemia by repressing serotonin activity in
cardiomyocytes via glucocorticoid inhibition of estrogen transcriptional regulation of the serotonin receptor 5-
HT2BR (implicated in cardioprotection through the regulation of mitochondrial function in cardiomyocytes). A
decrease in serotonin activity has been associated with increased risk of myocardial infarction in depressed
patients, and also polymorphisms in serotonin receptors are associated with elevated glucocorticoid response
linked to cardiovascular complications, including an increased incidence of heart attacks. Therefore, we aim to
elucidate estrogen regulatory mechanism of 5-HT2BR expression in the heart and the effects of glucocorticoids
on estrogen-mediated 5-HT2BR signaling in ischemia/reperfusion (I/R). We hypothesize that stress exerts
deleterious effects on the female heart in myocardial infarction by exacerbating mitochondrial dysfunction via
glucocorticoids inhibition of estrogen transcriptional regulation of 5-HT2BR in cardiomyocytes. We will investigate
this pathway by examining glucocorticoid and estrogen antagonism in cardiomyocytes, the effects of this
crosstalk in I/R (in vivo studies), and the molecular and physiological effects of 5-HT2BR regulation by estrogen
in mitochondrial function in ischemic conditions. If funded, this application will help me develop a scientifically
independent project, acquire training in the cardiovascular field, build a research team, enhance my mentoring
skills, and improve my grant writing skills to become competitive to apply to a major funding mechanism. My
current institution and my mentor and co-mentor will provide me with the necessary facilities and guidance to
accomplish these goals. Also, I will participate in training and career development activities that will strengthen
my scientific career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female Heart
-
批准号:10715407
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2023
-
负责人:Diana Cruz Topete
-
依托单位:
Molecular Mechanisms of Stress Signaling in the Female Heart
-
批准号:10327286
-
项目类别:
-
资助金额:$13.88万
-
财政年份:2020
-
负责人:Diana Cruz Topete
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: